Aripiprazole Oral Soluble Film(Qilu Pharma)

阿立哌唑口溶膜（齐鲁制药）

Report date: 2025/03/31 11:37:31

Base Information

Drug NameAripiprazole Oral Soluble Film(Qilu Pharma)
Drug Alias Name阿利哌唑阿立派唑阿立哌唑口溶膜（2.2类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor agonistsDopamine D4 receptor antagonists +[9] 
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptorDopamine D2 receptor +[9] 
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryMainland China
Original Approved Date2022/06/23
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG